Page 1

.
2021 Childhood Cancer Advocacy Initiative 

We are excited to have you with us! Looking forward to working with you to make a difference in state level advocacy on behalf of children with cancer. Sign the form below to help today.  
Demographic Information






Contact Information




Upcoming Traning Sessions 
Starting February 10, 2021, ACCO will be holding monthly advocacy meetings which are open to the public. Meetings will be held via Zoom at 7-8pm EST. Zoom links will be sent closer to the meeting date and recordings will be available if you miss a meeting.  

If you have any questions, please email our advocacy team at: 
  • Jamie Bloyd: jbloyd@acco.org
  • Aubrey Reichard-Eline: areichard-eline@acco.org 

The next page includes our Non Disclosure and Intellectual Property agreement. 
.
Advocate Non Disclosure & Intellectual Property Agreements 
Non Disclosure 
I. Purpose. This Advocate Non-Disclosure Agreement (NDA), referred to as the “Agreement,”
applied to

referred to as an American Childhood Cancer (ACCO) Volunteer Advocate, who is associated with and/or involved in ACCO’s advocacy programs, understands and agrees to the following.

II. Confidential Information. All data, materials, knowledge, and proprietary information generated through, originating from, or having to do with the ACCO’s Program(s), including their Advocacy Program(s) or persons associated with its activities, including contractors, is to be considered Confidential Information and is not to be disclosed to any outside party.
This includes but is not limited to any communication of any kind whether verbal, written or any
other form, and any information relating to technical data, know-how, research data, algorithms, business and product plans, surveys, messages (received or transmitted), resources, contacts, email lists, and email messages, whether internally between staff or outside the Advocacy Program is confidential and the sole property of the ACCO.

III. Clients. Client information, including all file information, is not to be disclosed to any third party under any circumstance without the written consent of ACCO.

IV. Damages. Any disclosure, misuse, copying, or transmitting of any material, data, or information, whether intentional or unintentional, will subject the advocate to potential disciplinary action, prosecution, and/or monetary damages according to the procedures set by the American Childhood Cancer Organization and any applicable laws.

The signature of the Volunteer below acknowledges his/her agreement to the aforementioned terms.
Intellectual Property 
Founded in 1970 by a dedicated group of parents of children with cancer, the American Childhood Cancer Organization (ACCO) is the oldest and largest grassroots childhood cancer organization in the U.S. and only U.S. member of Childhood Cancer International. We are dedicated to our mission of making childhood cancer a national health priority through shaping policy, supporting research, raising awareness, and providing educational resources and innovative programs to children with cancer, survivors, and their families.

In pursuit of achieving our mission and conducting our charitable activities, ACCO’s works of authorship, technical expertise, designs, program materials, registered trademarks, branding materials, and public and private relationships constitute ACCO’s Intellectual Property (IP).

The American Childhood Cancer Organization’s works of authorship, procedures and technical expertise,proprietary information, data, communications, designs, messages (received or transmitted), contact lists,
registered trademarks, or other items of commercial and non-commercial interest, created by or resulting from ACCO expertise, relationships, or research conducted by ACCO, including employees, contractors,
board members and/or volunteers are the sole Intellectual Property (IP) of ACCO and as such are not to be disclosed, copied, amended, conveyed, or laid claim to any other entity other than ACCO.
Acknowledgement
By signing this agreement, I agree to the aforementioned.